Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Geely: Unprecedented opportunity to accumulate the future Chinese auto technology leader

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul><li>We have a conference call with Geely's Executive Director Mr. Lawrence Ang to better understand Geely's technology road map </li><li>With M&amp;As globally, Geely is moving up the value chain in the automobile industry </li><li>We examine &nbsp;how these M&amp;As tie into Geely's long term technology leadership </li><li>We also examine the impact in 2015/2016 window</li></ul>

We have a conference call with Geely's Executive Director Mr. Lawrence Ang to better understand Geely's technology road map With M&amp;As globally, Geely is moving up the value chain in the automobile industry We examine &nbsp;how these M&amp;As tie into Geely's long term technology leadership We also examine the impact in 2015/2016 window

Geely: How M&As make up its long term technology road map and why that matters in 2015/2016

Geely Auto

Geely: How M&As make up its long term technology road map and why that matters in 2015/2016